MARSHALL WACE, LLP - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 24 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,811,000
-30.5%
160,062
-61.6%
0.01%
-33.3%
Q2 2021$4,044,000
-5.1%
416,924
+5.0%
0.02%
-10.0%
Q1 2021$4,263,000
+1084.2%
396,945
+1521.4%
0.02%
+900.0%
Q4 2020$360,000
+146.6%
24,482
-88.9%
0.00%
+100.0%
Q1 2019$146,000220,5640.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders